T. Aotsuka

Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.

N. Abe, N. Ashizawa, A. Matsuura, 1997, Japanese journal of pharmacology.

Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.

N. Ashizawa, A. Matsuura, Y. Sugiyama, 1998, Diabetes research and clinical practice.

Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats.

K. Takayama, K. Shimizu, S. Yonebayashi, 2003, International journal of pharmaceutics.

Possible involvement of different mechanisms in sudden death induced by endothelin-1 and big endothelin-1.

H. Okumura, N. Ashizawa, A. Matsuura, 1995, Biological & pharmaceutical bulletin.